CapEdge
Loading...
Advanced
What's new? Log in Free sign up
  • Home
  • Sectors & IndustriesSectors
  • Earnings
  • IPOs
  • SPACs
  • Transcripts
  • Insider
  • Institutional
  • Crypto
  • Screeners
  • Reddit
  • Splits
  • BLI Dashboard
  • Financials
  • Filings
  • Transcripts
  • ETFs
  • Insider
  • Institutional
  • Shorts
  • News
  • Patents
  • Reddit

Berkeley Lights (BLI)

Company Profile
Berkeley Lights, Inc. operates as a biotechnology company. The Company provides technology solutions for single cell manipulation for biopharma, diagnostics, and life science research. Berkeley Lights serves customers worldwide.
Berkeley Lights logo

Company profile

Ticker
BLI
Exchange
NASDAQ
Website
www.berkeleylights.com
CEO
Eric Hobbs
Employees
Incorporated
Delaware
Location
California
Fiscal year end
Dec 31
Sector
Manufacturing > Analytical Laboratory Instrument Manufacturing
Industry (SIC)
Laboratory Analytical Instruments
Agilent • Bio-Rad Laboratories • Waters • Illumina • Avantor • Mettler-Toledo International • Bruker • Perkinelmer • Seer • Cue Health ...
SEC CIK
0001689657
Corporate docs
Articles of Incorporation & Bylaws
Underwriting Agreements
Plans of Reorganization
Indentures
Material Contracts & Credit Agreements
Subsidiaries Lists
Subsidiaries
BLI Europe International, Ltd. • BLI International LLC • (Shanghai) Co., Ltd. • (Singapore) Pte., Ltd. ...
IRS number
352415390

BLI stock data

Latest filings (excl ownership)
View all
8-K
Departure of Directors or Certain Officers
26 Jan 23
425
Business combination disclosure
9 Jan 23
8-K
Berkeley Lights Reports Preliminary Full Year 2022 Revenue Results
9 Jan 23
425
Business combination disclosure
4 Jan 23
425
Business combination disclosure
23 Dec 22
425
Business combination disclosure
22 Dec 22
425
Business combination disclosure
22 Dec 22
425
Business combination disclosure
21 Dec 22
425
Business combination disclosure
21 Dec 22
8-K
Berkeley Lights to Acquire IsoPlexis, Creating a Premier Functional Cell Biology Company
21 Dec 22
Transcripts
View all
BLI
Earnings call transcript
2022 Q3
9 Nov 22
BLI
Earnings call transcript
2022 Q2
10 Aug 22
BLI
Earnings call transcript
2022 Q1
10 May 22
BLI
Earnings call transcript
2021 Q4
24 Feb 22
BLI
Earnings call transcript
2021 Q3
4 Nov 21
BLI
Earnings call transcript
2021 Q2
11 Aug 21
BLI
Earnings call transcript
2021 Q1
11 May 21
BLI
Earnings call transcript
2020 Q4
28 Feb 21
BLI
Earnings call transcript
2020 Q3
12 Nov 20
Latest ownership filings
View all
4
James Paul McClaskey
24 Jan 23
4
Siddhartha Kadia
13 Dec 22
4
Siddhartha Kadia
9 Dec 22
4
James Paul McClaskey
22 Nov 22
4
Eric Hobbs
22 Nov 22
4
Keith Breinlinger
22 Nov 22
4
James Paul McClaskey
24 Oct 22
4
Scott David Chaplin
21 Sep 22
3
Scott David Chaplin
21 Sep 22
4
Keith Breinlinger
19 Sep 22

Financial summary

Financial statements Chart BLI financial data
Quarter (USD) Sep 22 Jun 22 Mar 22 Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD) Dec 21 Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Cash burn rate (est.) Burn method: Change in cash Burn method: Operating income Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 120.64 mm 120.64 mm 120.64 mm 120.64 mm 120.64 mm 120.64 mm
Cash burn (monthly) 7.46 mm 6.39 mm 7.18 mm 7.21 mm 5.64 mm 4.33 mm
Cash used (since last report) 29.55 mm 25.29 mm 28.44 mm 28.57 mm 22.33 mm 17.13 mm
Cash remaining 91.09 mm 95.35 mm 92.20 mm 92.07 mm 98.31 mm 103.51 mm
Runway (months of cash) 12.2 14.9 12.8 12.8 17.4 23.9

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2022

BLI institutional ownership history Ownership history
77.0% owned by funds/institutions
13F holders Current Prev Q Change
Total holders 102 121 -15.7%
Opened positions 12 21 -42.9%
Closed positions 31 27 +14.8%
Increased positions 31 49 -36.7%
Reduced positions 35 32 +9.4%
13F shares Current Prev Q Change
Total value 285.43 mm 1.27 bn -77.6%
Total shares 52.78 mm 56.34 mm -6.3%
Total puts 12.30 k 20.40 k -39.7%
Total calls 19.00 k 38.20 k -50.3%
Total put/call ratio 0.6 0.5 +21.2%
Largest owners Shares Value Change
Igor Y Khandros 8.78 mm $159.68 mm 0.0%
ARK Investment Management 5.47 mm $15.64 mm -35.1%
BLK Blackrock 4.96 mm $14.18 mm -1.0%
MKFCF Mackenzie Financial 4.18 mm $11.96 mm -0.5%
Baillie Gifford & Co 3.72 mm $10.63 mm +1.1%
Vanguard 3.07 mm $8.79 mm +26.8%
Glenview Capital Management 2.33 mm $6.65 mm 0.0%
FHI Federated Hermes 2.18 mm $6.22 mm -13.2%
Nierenberg Investment Management 2.06 mm $5.90 mm +162.5%
JPM JPMorgan Chase & Co. 1.62 mm $4.63 mm +17.8%
Largest transactions Shares Bought/sold Change
ARK Investment Management 5.47 mm -2.95 mm -35.1%
Nierenberg Investment Management 2.06 mm +1.28 mm +162.5%
STT State Street 0.00 -1.08 mm EXIT
Vanguard 3.07 mm +650.54 k +26.8%
Jacobs Levy Equity Management 0.00 -607.01 k EXIT
MS Morgan Stanley 1.54 mm -331.83 k -17.8%
FHI Federated Hermes 2.18 mm -331.37 k -13.2%
Parian Global Management 88.98 k -292.52 k -76.7%
JPM JPMorgan Chase & Co. 1.62 mm +244.09 k +17.8%
Aqr Capital Management 267.27 k +244.05 k +1050.9%
Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

BLI insider ownership history Insider history
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
20 Jan 23 James Paul McClaskey Common Stock Payment of exercise Dispose F No No 2.22 143 317.46 65,072
9 Dec 22 Siddhartha Kadia Common Stock Payment of exercise Dispose F No No 2.64 36,975 97.61 k 923,660
7 Dec 22 Siddhartha Kadia Common Stock Payment of exercise Dispose F No No 2.53 150 379.50 960,635
20 Nov 22 Keith Breinlinger Common Stock Payment of exercise Dispose F No No 2.93 1,565 4.59 k 151,743
20 Nov 22 Keith Breinlinger Common Stock Payment of exercise Dispose F No No 2.93 4,015 11.76 k 153,308
20 Nov 22 Keith Breinlinger Common Stock Payment of exercise Dispose F No No 2.93 119 348.67 157,323
20 Nov 22 Eric Hobbs Common Stock Payment of exercise Dispose F No No 2.93 23,011 67.42 k 129,201
20 Nov 22 Eric Hobbs Common Stock Payment of exercise Dispose F No No 2.93 478 1.40 k 152,212
Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

News

From Benzinga Pro
12 Health Care Stocks Moving In Thursday's After-Market Session
12 Jan 23
Berkeley Lights' Preliminary 2022 Results Deficient, Analysts Say All Eyes On IsoPlexis Execution
10 Jan 23
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
10 Jan 23
Gainers
12 Health Care Stocks Moving In Monday's After-Market Session
9 Jan 23
Why Applied Molecular Transport Shares Are Trading Lower By Over 55%? Here Are 47 Stocks Moving In Friday's Mid-Day Session
23 Dec 22

Press releases

From Benzinga Pro
Berkeley Lights Reports Preliminary Full Year 2022 Revenue Results
9 Jan 23
EMERYVILLE, Calif., Jan. 9, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (NASDAQ:BLI), a life sciences tools company, today announced preliminary unaudited revenue results for the full year ended December 31, 2022. Total
Berkeley Lights Launches Beacon Select™, A New Optofluidic System For Cell Line Development
9 Jan 23
New, two-chip, single-cell optofluidic system ideal for small- to mid-sized biopharma & CDMOs/CROs to affordably gain access to the Beacon® technology and cell line development-specific applications EMERYVILLE,
Berkeley Lights to Participate in the 41st Annual J.P. Morgan Healthcare Conference
3 Jan 23
EMERYVILLE, Calif., Jan. 3, 2023 /PRNewswire/ -- Berkeley Lights, Inc. (NASDAQ:BLI), a life sciences tools company, today announced the Company will be participating in the upcoming 41st Annual J.P. Morgan Healthcare
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HZN, BLI, ISO, CBIO
3 Jan 23
ISOPLEXIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of IsoPlexis Corporation - ISO
30 Dec 22
Finsight
Resources
  • Knowledgebase
  • Log In
  • Register
Company
  • About
  • Contact
  • Solutions
Products
  • Deal Roadshow
  • DealVDR
  • Evercall
  • Finsight.com
CapEdge
  • Earnings Calendar
  • Earnings Transcripts
  • EDGAR Filing Screener
  • IPO Calendar
  • Compliance
  • Privacy
  • Security
  • Terms
AngelList LinkedIn